Similar articles

Abstract: immune thrombocytopenia (ITP) is a hemorrhagic autoimmune disease characterized by antibody-mediated platelet injury. ITP has complicated immunopathological mechanisms that need further elucidation. It is well known that the costimulatory molecules OX40 ligand (OX40L) and OX40 play essential roles in the immunological mechanisms of autoimmune diseases. Previously, we discovered that the expression ofOX40L andOX40 is significantly increased in the peripheral blood mononuclear cells (PBMCs) of ITP patients. In our present study, OX40L-induced follicular helper T (Tfh) cells exhibited an activated phenotype with elevated expression of inducible T-cell costimulator (ICOS), programmed cell death protein-1 (PD-1), and cluster of differentiation 40 ligand (CD40L) in vitro. Moreover, aberrant OX40L‒OX40 expression might promote the Tfh1-to-Tfh2 shift in vivo, inducing the generation of autoantibodies by enhancing the helper function of Tfh cells for B lymphocytes in a mouse model, which might accelerate the progression of ITP. Additionally, signal transduction through the OX40L‒OX40 axis might be related to the activation of tumor necrosis factor receptor-associated factor (TRAF)‒nuclear factor-κB (NF-κB) and Janus kinase (JAK)‒signal transducer and activator of transcription (STAT) signaling pathways. Overall, OX40L‒OX40 signaling is proposed as a potential novel therapeutic target for ITP.

OX40配体促进免疫性血小板减少症小鼠的滤泡辅助性T细胞分化和发育

[1]AnJN,DingSS,HuXH,et al.,2019.Preparation, characterization and application of anti-human OX40 ligand (OX40L) monoclonal antibodies and establishment of a sandwich ELISA for autoimmune diseases detection.Int Immunopharmacol,67:260-267.

[2]AudiaS,RossatoM,SantegoetsK,et al.,2014.Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia.Blood,124(18):2858-2866.

[3]AudiaS,MahévasM,NivetM,et al.,2021.Immune thrombocytopenia: recent advances in pathogenesis and treatments.Hemasphere,5(6):e574.

[4]BonamiRH,NyhoffLE,McNittDH,et al.,2020.T‒B lymphocyte interactions promote type 1 diabetes independently of SLAM-associated protein. J Immunol,205(12):3263-3276.

[5]BursteinSA,FrieseP,DownsT,et al.,1992.Characteristics of a novel rat anti-mouse platelet monoclonal antibody: application to studies of megakaryocytes.Exp Hematol,20(10):1170-1177.

[6]CazaT,WijewardenaC,Al-RabadiL,et al.,2022.Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis.Transl Res,245:55-81.

[7]ChenYW,LuoLP,ZhengYZ,et al.,2022.Association of platelet desialylation and circulating follicular helper T cells in patients with thrombocytopenia.Front Immunol,13:810620.

[8]CinesDB,2023.Pathogenesis of refractory ITP: overview.Br J Haematol,203(1):10-16.

[9]CuiDW,LvY,YuanXW,et al.,2019.Increased expressions of OX40 and OX40 ligand in patients with primary immune thrombocytopenia.J Immunol Res,2019:6804806.

[10]EdnerNM,CarlessoG,RushJS,et al.,2020.Targeting co-stimulatory molecules in autoimmune disease.Nat Rev Drug Discov,19(12):860-883.

[11]FuNN,XieF,SunZW,et al.,2021.The OX40/OX40L axis regulates T follicular helper cell differentiation: implications for autoimmune diseases.Front Immunol,12:670637.

[12]FuY,LinQ,ZhangZR,et al.,2020.Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity.Acta Pharm Sin B,10(3):414-433.

[13]FurueM,FurueM,2021.OX40L‒OX40 signaling in atopic dermatitis. J Clin Med,10(12):2578.

[14]GhanimaW,GernsheimerT,KuterDJ,2021.How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment.Blood,137(20):2736-2744.

[15]GuoL,KapurR,AslamR,et al.,2018.Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.Scand J Immunol,88(1):e12678.

[16]HeY,XuLL,FengFE,et al.,2018.Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.Br J Haematol,180(3):395-411.

[17]Hernandez-MolinaG,Soto-AbrahamV,Zamora-LegoffV,et al.,2021.Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjögren’s syndrome and systemic lupus erythematosus associated with Sjögren’s syndrome.Clin Exp Rheumatol,39(6Suppl 133):49-56.

[18]IrikiH,TakahashiH,AmagaiM,2023.Diverse role of OX40 on T cells as a therapeutic target for skin diseases.J Invest Dermatol,143(4):545-553.

[19]JacqueminC,SchmittN,Contin-BordesC,et al.,2015.OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response.Immunity,42(6):1159-1170.

[20]JacqueminC,AugustoJF,ScherlingerM,et al.,2018.OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.JCI Insight,3(24):e122167.

[21]JensenO,TrivediS,MeierJD,et al.,2022.A subset of follicular helper-like MAIT cells can provide B cell help and support antibody production in the mucosa.Sci Immunol,7(67):eabe8931.

[22]LiX,WangSW,FengQ,et al.,2019.Novel murine model of immune thrombocytopaenia through immunized CD41 knockout mice.Thromb Haemost,119(3):377-383.

[23]LiuB,LinYH,YanJC,et al.,2021.Affinity-coupled CCL22 promotes positive selection in germinal centres.Nature,592(7852):133-137.

[24]LiuXG,HouY,HouM,2023.How we treat primary immune thrombocytopenia in adults.J Hematol Oncol,16:4.

[25]Mingot-CastellanoME,BastidaJM,Caballero-NavarroG,et al.,2022.Novel therapies to address unmet needs in ITP.Pharmaceuticals,15(7):779.

[26]MoritaR,SchmittN,BentebibelSE,et al.,2011.Human blood CXCR5⁺CD4⁺ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.Immunity,34(1):108-121.

[27]NagashimaH,IshiiN,SoT,2018.Regulation of interleukin-6 receptor signaling by TNF receptor-associated factor 2 and 5 during differentiation of inflammatory CD4⁺ T cells.Front Immunol,9:1986.

[28]National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals,2011.Guide for the Care and Use of Laboratory Animals.8th Edition. National Academies Press (US), Washington DC.https://www.ncbi.nlm.nih.gov/sites/books/NBK54049

[29]PedrosC,AltmanA,KongKF,2018.Role of TRAFs in signaling pathways controlling T follicular helper cell differentiation and T cell-dependent antibody responses.Front Immunol,9:2412.

[30]PontariniE,Murray-BrownWJ,CroiaC,et al.,2020.Unique expansion of IL-21⁺ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma.Ann Rheum Dis,79(12):1588-1599.

[31]SasakiT,BraceroS,KeeganJ,et al.,2022.Longitudinal immune cell profiling in patients with early systemic lupus erythematosus.Arthritis Rheumatol,74(11):1808-1821.

[32]SchmittN,BentebibelSE,UenoH,2014.Phenotype and functions of memory Tfh cells in human blood.Trends Immunol,35(9):436-442.

[33]ShesternyaPA,SavchenkoAA,GritsenkoOD,et al.,2022.Features of peripheral blood Th-cell subset composition and serum cytokine level in patients with activity-driven ankylosing spondylitis.Pharmaceuticals,15(11):1370.

[34]SitrinJ,SutoE,WusterA,et al.,2017.The Ox40/Ox40 ligand pathway promotes pathogenic Th cell responses, plasmablast accumulation, and lupus nephritis in NZB/W F1 mice.J Immunol,199(4):1238-1249.

[35]SoT,SorooshP,EunSY,et al.,2011.Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells.Proc Natl Acad Sci USA,108(7):2903-2908.

[36]SunCH,YangJ,WangMZ,et al.,2018.Icaritin improves antibody-induced thrombocytopenia in a mouse model by regulating T-cell polarization.Planta Med,84(3):168-175.

[37]VernavaI,SchmittCA,2023.Daratumumab as a novel treatment option in refractory ITP.Blood Cells Mol Dis,99:102724.

[38]VianelliN,AuteriG,BuccisanoF,et al.,2022.Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.Ann Hematol,101(5):963-978.

[39]VictoraGD,NussenzweigMC,2022.Germinal centers.Annu Rev Immunol,40:413-442.

[40]WangL,XuL,HaoHY,et al.,2020.First line treatment of adult patients with primary immune thrombocytopenia: a real-world study.Platelets,31(1):55-61.

[41]WeiXD,NiuXY,2023.T follicular helper cells in autoimmune diseases.J Autoimmun,134:102976.

[42]XiaoX,BalasubramanianS,LiuWT,et al.,2012.OX40 signaling favors the induction of T_H9 cells and airway inflammation.Nat Immunol,13(10):981-990.

[43]XuY,XuHM,ZhenY,et al.,2019.Imbalance of circulatory T follicular helper and T follicular regulatory cells in patients with ANCA-associated vasculitis.Mediators Inflamm,2019:8421479.

[44]YangWS,CuiXH,SunDP,et al.,2023.POU5F1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6.Cell Death Dis,14(12):802.

[45]YuYY,ShiYY,ZuoXY,et al.,2018.Progranulin facilitates the increase of platelet count in immune thrombocytopenia.Thromb Res,164:24-31.

[46]ZhaoH,GuZW,WangYX,et al.,2022.IL-9 neutralizing antibody suppresses allergic inflammation in ovalbumin-induced allergic rhinitis mouse model.Front Pharmacol,13:935943.